Product Name

  • Name

    Kallikrein

  • EINECS 232-574-5
  • CAS No. 9001-01-8
  • Density
  • Solubility Soluble in water (10%), diluted alcohol, insoluble in concentrated ethanol and general organic solvents
  • Melting Point
  • Formula
  • Boiling Point
  • Molecular Weight 0
  • Flash Point
  • Transport Information
  • Appearance White or off-white powder
  • Safety
  • Risk Codes
  • Molecular Structure Molecular Structure of 9001-01-8 (Kallikrein)
  • Hazard Symbols ExplosiveB
  • Synonyms Arginineesteropeptidase;Bradykininogenase;Callicrein;Circuletin;Depot-Glumorin;Depot-Padutin;Dilminal D;E.C. 3.4.21.8;E.C. 3.4.4.21;Follipsin;Glumorin;Kalirechin;Kallidinogenase;Kallikrein esterase;Kininogenase;Kininogenin;Onokrein P;Padreatin;Padukrein;Padutin;Pancreatic kallikrein;Prokrein;Promotin;Urinary kallikrein;Urokallikrein;Yikai;SK 827;Substance R (enzyme);
  • PSA 0.00000
  • LogP 0.00000

Kallikrein Specification

The Kallikrein, with the CAS registry number 9001-01-8, is also known as Kallidinogenase. Its EINECS number is 232-572-4. Its classification codes are: (1)Coagulants; (2)Drug / Therapeutic Agent; (3)Fertility Agents; (4)Fertility Agents, Male; (5)Hematologic Agents; (6)Mutation data; (7)Reproductive Control Agents; (8)Reproductive Effect. Its storage temperature is 2-8°C. Moreover, it should be protected from light. It is mainly used as vasodilator. What's more, it can be used to cure cerebral arteriosclerosis, endarteritisobliterans, essential hypertension, angina, thromboangiitisobliterans. It is synthesised as an inactive precursor, prekallikrein, which must undergo proteolytic processing to become activated.

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous > 40mL/kg (40mL/kg)   Kiso to Rinsho. Clinical Report. Vol. 27, Pg. 2589, 1993.
mouse LD50 oral > 40mL/kg (40mL/kg)   Kiso to Rinsho. Clinical Report. Vol. 27, Pg. 2589, 1993.
mouse LD50 subcutaneous > 40mL/kg (40mL/kg)   Kiso to Rinsho. Clinical Report. Vol. 27, Pg. 2589, 1993.
rat LD50 intravenous > 40mL/kg (40mL/kg) KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED Kiso to Rinsho. Clinical Report. Vol. 27, Pg. 2589, 1993.
rat LD50 oral > 40mL/kg (40mL/kg)   Kiso to Rinsho. Clinical Report. Vol. 27, Pg. 2589, 1993.
rat LD50 subcutaneous > 40mL/kg (40mL/kg)   Kiso to Rinsho. Clinical Report. Vol. 27, Pg. 2589, 1993.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View